Parameter
| Biomarker | CDKN2A, CTSV, FOXM1 | Full name | Cyclin-dependent kinase inhibitor 2A,Cathepsin V,Forkhead box M1 | Molecular Type | Nucleic acid (mRNA) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, prognosis & progression prediction |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue (qRT-PCR, bioinformatics) | ||
| Pathobiological Mechanisms | Combined signature shows 95.5 % sensitivity & 100 % specificity for progression; involved in tumour-related biology | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Multi-gene panel improves prognostic accuracy; clinical implementation pending | ||||